[Effects of beta-adrenergic compounds on IgE production]

O Coqueret1, V Lagente

  • 1Molecular Oncology group, Royal Victoria Hospital, McGill University, Montreal, Québec, Canada.

Allergie Et Immunologie
|December 1, 1995
PubMed

Insights

Beta 2-adrenoceptor agonists, used for asthma, increase immunoglobulin E (IgE) production. This occurs both in lab settings and in living organisms, potentially impacting allergic responses.

Area of Science:

  • Immunology
  • Pharmacology
  • Allergy Research

Background:

  • Beta 2-adrenoceptor agonists are common asthma medications.
  • Their effect on immunoglobulin E (IgE) production, a key allergic mediator, requires further investigation.

Purpose of the Study:

  • To investigate the impact of beta 2-adrenoceptor agonists on IgE production.
  • To explore the mechanisms underlying these effects in both human and murine models.

Main Methods:

  • In vitro studies using human peripheral blood mononuclear cells and purified B lymphocytes.
  • In vivo studies involving ovalbumin-sensitized mice.
  • Analysis of IgE production, mRNA expression, cytokine profiles, and effects of signaling pathway modulators (cAMP, PKA inhibitors).

Main Results:

  • Salbutamol and fenoterol potentiated Interleukin-4 (IL-4)-induced IgE production in human cells.
  • This potentiation correlated with increased IgE mRNA expression.
  • Fenoterol also enhanced IgE production in purified B cells and inhibited T-lymphocyte IFN-gamma production.
  • In vivo, salbutamol increased IgE responses in ovalbumin-sensitized mice, associated with Th2 cytokine shifts.
  • The effects were linked to cAMP-PKA signaling pathways.

Conclusions:

  • Beta 2-adrenoceptor agonists can enhance IgE production through mechanisms involving T-lymphocyte or monocyte modulation.
  • These findings suggest a potential link between common asthma treatments and exacerbation of allergic responses.
  • Further research is warranted to understand the clinical implications for allergic patients.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...